Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program

por Cetin, Karynsa, Ettinger, David S, Hei, Yong-jiang, O’Malley, Cynthia D
Publicado 2011

Challenges in Developing a Validated Biomarker for Angiogenesis Inhibitors: The Motesanib Experience

por Bass, Michael B., Yao, Bin, Hei, Yong-Jiang, Ye, Yining, Davis, Gerard J., Davis, Michael T., Kaesdorf, Barbara A., Chan, Sabrina S., Patterson, Scott D.
Publicado 2014

The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumors

por Rosen, Lee S, Lipton, Lara, Price, Timothy J, Belman, Neil D, Boccia, Ralph V, Hurwitz, Herbert I, Stephenson Jr, Joe J, Wirth, Lori J, McCoy, Sheryl, Hei, Yong-jiang, Hsu, Cheng-Pang, Tebbutt, Niall C
Publicado 2013